Hudson-Essex Allergy
Belleville, New Jersey, United States
Allergist in Belleville, New Jersey
5 Franklin Ave #102, Belleville, NJ 07109
About Hudson-Essex Allergy
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Hudson-Essex Allergy
During the past decade, Hudson-Essex Allergy conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on
average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer
2000-10-01
Unknown status
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
2008-08-08
Active, not recruiting
403
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
2010-06-01
Active, not recruiting
2,527
Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
2011-01-24
2027-07-20
Active, not recruiting
226
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery
2011-05-25
Active, not recruiting
1,673
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
2012-02-01
2019-09-19
Completed
213
PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery
2012-06-12
2023-06-30
Active, not recruiting
1,194
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
2013-04-01
2030-01-01
Active, not recruiting
1,900
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hudson-Essex Allergy"
#1 collaborator was "Dyax Corp." with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Hudson-Essex Allergy
According to Clinical.Site data, the most researched conditions in "Hudson-Essex Allergy" are
"Hereditary Angioedema (HAE)" (3 trials), "Angioedema" (1 trials), "Hereditary Angioedema" (1 trials) and "Peanut Allergy" (1 trials). Many other conditions were trialed in "Hudson-Essex Allergy" in a lesser frequency.
Clinical Trials Intervention Types at Hudson-Essex Allergy
Most popular intervention types in "Hudson-Essex Allergy" are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "DX-2930" (1 trials), "DX-2930 - 150mg/4wk" (1 trials), "DX-2930 - 300mg/2wk" (1 trials) and "DX-2930 - 300mg/4wk" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hudson-Essex Allergy
The vast majority of trials in "Hudson-Essex Allergy" are
5 trials for "All" genders.
Clinical Trials Status at Hudson-Essex Allergy
Currently, there are NaN active trials in "Hudson-Essex Allergy".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Hudson-Essex Allergy,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hudson-Essex Allergy, 1 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".